Exothera, a provider of nucleic acids and viral vector development and manufacturing services, has launched a new nucleic acids service offering powered by a continuous-batch RNA production platform, Ntensify. About the Ntensify Platform Developed by Exothera sister company Quantoom Biosciences, the Ntensify platform is designed to fast-track the production of higher quality and more cost-effective RNA therapeutics, delivering significant advantages at both small and large scale. It is also...